SORT BY Relevancy
In the hour, we explore the post diagnostic implications of whole exome sequencing as it pertains to clinical practice with some eye opening data from our two speakers Julie Cohen and Dr. Alejandro Iglesias. Julie is a Genetic Counselor at Kennedy Kreiger Institute in Baltimore Maryland, and Dr. Alejandro Iglesias has been a pediatrician and geneticist for the last 25 years.
Curing vision loss, growing new skin for burn patients, growing blood vessels, and curing neurological diseases. These are a few of the proposed benefits from stem cell therapy. Embryonic stem cell research has been a source of political debate and controversy, but adult stem cells exist throughout our body after embryonic development and there is some evidence to suggest that they can differentiate to become other cell types. This potential capacity for adult stem cells to be instructed to specialize interests scientists and researchers who hope it will lead to a cure for Parkinson's and other neurological diseases.
Separating stem cell fact from fiction will be the role of my guest, Dr. Juan R. Sanchez-Ramos, Movement Disorders Professor and Researcher, Department of Neurology, USF Health, Tampa, Fl. Dr. Ramos’ Clinical interests include: neurodegenerative diseases with focus on Huntington’s and Parkinson's disease. His research interests include: neurodegeneration, neurotoxicology and adult stem cell biology. Dr. Ramos is the Medical Director for the Parkinson Research Foundation, and provides monthly Ask the Doctor lectures at its community based program, Parkinson Place in Sarasota, Florida.
As always, YOU can join the discussion by calling in on the toll free number, sending an email or tweet.
Listen, learn, and join the discussion. Call toll free: (888) 787-5265 or SKYPE Email: firstname.lastname@example.org or send a tweet: @voiceaerobics#parkinsons #stemcells
Welcome to Alzheimer's Speaks Radio where we listen to all voices on dementia.
Our first guest Jane Sweeney, used a pen name of JC to write "Caregiver: My Love Story, Facing Dementia." This is a powerful and very "caregiver friendly" book. The book is her tribute to her sweetheart Bernie, to honor his love. Jane wanted and needed to share what she learned. By giving to others tips she learned from her own journey, Jane hopes to bring awareness to the difficulties faced by so many walking this path.
Our second guest will be Dr. Shubin is active in research for dementia. As the Director and Principal Investigator of Neuro-Therapeutics, Inc., he provides opportunities for those diagnosed to be involved in cutting edge research in neurology. Today, he will talk to use about a phase 3 clinical study. The trial involves LMTX, a Tau protein aggregation inhibitor for patients with early Alzheimers. LMTX™ acts by reducing levels of aggregated or misfolded Tau proteins, which are associated with the progressive neurodegeneration of Alzheimer’s disease.
For more information contact Keeley Fernandez, Study Coordinator by Email (626)250-2070 ex 730
Check out Alzheimer's Speaks Website for more resources and information - Blog, Free Webinars, Tools, Resource Directory and more.
MONDAY, MAY 21 - 2012, 3:30 pm PST/6:30 pm EST
Steven Finkbeiner, MD, PhD
Director, Taube-Koret Center for
Huntington's Disease Research
Senior Investigator and Associate Director,
Gladstone Institute of neurological Disease
Professor of Neurology and Physiology,
University of California, San Francisco
Areas of Investigation
Research in his laboratory focuses on molecular mechanisms of plasticity and neurodegeneration. A long- term goal of his research is to understand how neuronal activity elicits changes in gene expression that are important for learning and memory and aims to understand how an inherited genetic mutation leads to neuronal dysfunction and degeneration in Huntington's disease (HD).
Dr. Finkbeiner will be with us to give us his research updates.
C-terminus of the NMDA receptor couple Ca2+influx
Gene targets of the NMDA receptor
Subsynaptic protein translation in learning and memory
Polyglutamine expansion degeneration in neurons
Ubiquitination and proteasome function in
Normal function of huntingtin
Predictors of neurodegeneration
Monday, April 16, 2012 at 3:30 pm PST/6:30 pm EST
Dr. Paul Muchowsli is Associate Investigator at Gladstone Institute of Neurological Disease and Associate Professor of Neurology at UCSF in California.
The major research goal of his lab is to understand the molecular mechanisims that underlie neurodegenerative disorders associated with protein musfolding and aggregation, focusing on Alzheimer's disease (AD), Huntington's disease (HD) and Parkinson's disease (PD). The long-term goal is to use information gained from mechanism-based approaches to identify novel therapeutic targets for small molecules that could prevent neurodegeneration in humans.
This is going to be a very interesting and challenging episode.
Show is at 5pm PT / 8pm ET
"Modern life causes diabetes, autoimmunity, cancer, neurodegeneration, and infertility." Well then, let's do it like they used to! Robb Wolf, research biochemist, strength coach, and author of The Paleo Solution: The Original Diet, joins Dr Lo to discuss the paleo diet AND lifestyle. Topics include paleo nutrition, proper sleep, exercise. You'll get practical tips of how to make this paleo way of life do-able and fun. Hosted by Dr Lauren "Lo" Noel
Monday, June 6, 2011 – Our incredible special guest is Steven Hersch, MD, PhD, Professor of Neurology at Massachusetts General Hospital and Harvard Medical School; Director, Laboratory of Neurodegeneration and Neurotherapeutics, MassGeneral Institute for Neurodegeneration; Director, New England HDSA Center of Excellence for Huntington’s Disease at MGH; Co-chair, Huntington Study Group; Principal Investigator of the CREST-E study; and Principal Investigator of the REVEAL-HD study.
“The central focus of my professional work is to care for families with Huntington’s disease (HD) and to help develop treatments to slow or cure this fatal progressive neurogenetic disorder.” Steven Hersch, MD, PhD